News

Antiphospholipid, thrombosis histories differently affect pregnancy antithrombotic needs


 

EXPERT ANALYSIS FROM THE WINTER RHEUMATOLOGY SYMPOSIUM

"It’s worth talking to the woman before pregnancy and explaining that, unfortunately, pregnancy loss is not necessarily the worst thing that can happen. Her health can also be at risk," Dr. Clowse observed.

In her own practice, everybody with APS goes on aspirin at 81 mg/day throughout pregnancy, even if there has been no prior pregnancy loss. With a history of three or more consecutive pregnancy losses, the treatment is low-dose LMW heparin plus low-dose aspirin. In women with a history of pregnancy loss that doesn’t reach that level, there is no good evidence to provide guidance as to whether to use low-dose LMW heparin plus aspirin or aspirin alone; however, she tends to be more aggressive in women with lupus anticoagulant or very high titers of the other aPLs. Women with a history of thrombosis, whether arterial or venous, are encouraged to remain on full-dose LMW heparin plus low-dose aspirin throughout pregnancy.

Dr. Clowse reported serving as a consultant to UCB.

bjancin@frontlinemedcom.com

Pages

Recommended Reading

Bone mineral density identifies fracture risk in women over 65
MDedge Endocrinology
Soda pop boosts rheumatoid arthritis risk
MDedge Endocrinology
Knee osteoarthritis often overlooked in the obese
MDedge Endocrinology
Unsuspected primary hyperparathyroidism common in fibromyalgia patients
MDedge Endocrinology
No survival benefit to bisphosphonate in chemoresistant breast cancer
MDedge Endocrinology
FDA: Stop prescribing combo drugs with high-dose acetaminophen
MDedge Endocrinology
FDA: Naproxen may pose lower CV risk
MDedge Endocrinology
NSAID makers argue against new warnings on CV risks
MDedge Endocrinology
No new cardiovascular warnings needed for NSAIDs say FDA advisers
MDedge Endocrinology
NIH and pharma partner on RA, lupus, diabetes, Alzheimer’s research
MDedge Endocrinology